Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet clinical trials

Explore recruiting patient with non segmental symmetrical vitiligo with a body surface area involved 5 excluding hands and feet clinical trials.

Also recruiting in Europe

Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and tolerance of the association of ANIFROLUMAB (300mg) IV every four weeks and phototherapy versus phototherapy in adults with progressive vitiligo: a randomized double blind prospective, non comparative Proof of Concept phase II study - VITANI

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet trials by city

Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Toronto Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Vancouver Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Montreal Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Calgary Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Edmonton Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Ottawa Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Winnipeg Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Quebec City Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Hamilton Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Kitchener Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in London Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Halifax Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in New York Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Los Angeles Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Chicago Patient With Non Segmental Symmetrical Vitiligo With A Body Surface Area Involved 5 Excluding Hands And Feet in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease